Back to Search
Start Over
Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients
- Source :
- Revista espanola de cardiologia (English ed.).
- Publication Year :
- 2022
-
Abstract
- Data de publicació electrònica: 20-01-2023 Introduction and objectives: Dual antiplatelet therapy (DAPT) duration after ST-segment elevation myocardial infarction (STEMI) remains a matter of debate. Methods: We analyzed the effect of DAPT on 5-year all-cause mortality, cardiovascular mortality, and cardiovascular readmission or mortality in a cohort of 1-year survivor STEMI patients. Results: A total of 3107 patients with the diagnosis of STEMI were included: 93% of them were discharged on DAPT, a therapy that persisted in 275 high-risk patients at 5 years. Cardiovascular mortality in patients on single antiplatelet therapy vs DAPT at 5 years was 1.4% vs 3.6% (P
Details
- ISSN :
- 18855857
- Database :
- OpenAIRE
- Journal :
- Revista espanola de cardiologia (English ed.)
- Accession number :
- edsair.doi.dedup.....360400f104d2ea168b23bc1f1001beca